The Patent Finder

Lam Therapeutics, Inc.

Also on record
Records under this name other than patents Lam Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Lam Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,307,370Rapamycin for the Treatment of Lymphangioleiomyomatosis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,307,371Rapamycin for the Treatment of Lymphangioleiomyomatosis
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,123,289Rapamycin for the Treatment of Lymphangioleiomyomatosis
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,171,874Rapamycin for the Treatment of Lymphangioleiomyomatosis
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,744,797Rapamycin for the Treatment of Lymphangioleiomyomatosis
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,179,135Apilimod Compositions and Methods for Using Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,103,449An Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,648,199Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,491,143Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,206,910Apilimod for Use in the Treatment of Renal Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited